A TYPICAL AND MALIGNANT MENINGIOMAS - AN OUTCOME REPORT OF 17 CASES

Citation
Cc. Coke et al., A TYPICAL AND MALIGNANT MENINGIOMAS - AN OUTCOME REPORT OF 17 CASES, Journal of neuro-oncology, 39(1), 1998, pp. 65-70
Citations number
15
Categorie Soggetti
Clinical Neurology",Oncology
Journal title
ISSN journal
0167594X
Volume
39
Issue
1
Year of publication
1998
Pages
65 - 70
Database
ISI
SICI code
0167-594X(1998)39:1<65:ATAMM->2.0.ZU;2-E
Abstract
Limited data are available concerning the outcome of patients with aty pical and malignant meningiomas. We therefore analyzed the outcome of seventeen patients with meningiomas (9 atypical; 8 malignant) at Thoma s Jefferson University Hospital between 1973 and 1996. Strict adherenc e to the 1993 WHO criteria for the typing of CNS tumors was maintained . The median potential follow-up period for all patients was 87 months . The age at diagnosis ranged from 22 to 72 (mean 51.8 years). There w ere 5 males and 12 females. The mean tumor diameter was 4.45 cm. Of th e 16 cases where the extent of surgical resection was known, 4 were pa rtial and 12 were complete resections. Six patients (35%) had dural or cortical invasion by tumor. Fifteen patients received postoperative m egavoltage photon irradiation (mean 61 Gy). One of these fifteen pts. received an additional 20 Gy with Au-198 implantation and 1 received p ost-radiation chemotherapy for recurrent disease. The overall survival rate for all patients at 5 and 10 years were 87% and 58% respectively . The 5- and 10-year survival rates for atypical meningiomas were 87% and 58%; for malignant meningiomas the survival rates were 60% and 60% respectively. Five patients (30%) have died. Three of these 5 patient s initially received less than 54 Gy to the tumor bed and have died of recurrent disease. Local disease progression was documented in 11 pat ients (65%) after surgery and in 3 patients (18%) after radiation. The re was an improvement in performance status in 3 (18%) paients with a decline and no change seen in 1 (6%) and 13 (77%) respectively after r eceiving radiation. There appeared to be no difference in survival in patients as a function of dural or cortical invasion. Long term surviv al is possible for patients with atypical and malignant meningiomas tr eated with surgery and post-operative radiation. We are unable to dist inguish a difference in outcome between these two pathological entitie s. Dural and cortical invasion were not associated with a decrease in survival. In addition, improved tumor control and survival may be asso ciated with increased radiation dose.